Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karamchand

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
JMIR Research Protocols|March 10, 2025
Novel Versus Conventional Sequencing of β-Blockers, Sodium/Glucose Cotransportor 2 Inhibitors, Angiotensin Receptor-Neprilysin Inhibitors, and Mineralocorticoid Receptor Antagonists in Stable Patients With Heart Failure With Reduced Ejection Fraction (NovCon Sequencing Study): Protocol for a Randomized Controlled TrialSumanth Karamchand, Tsungai Chipamaunga, Poobalan Naidoo, et al.
Annals of Translational Medicine|November 17, 2022
Image-guided percutaneous biopsy and pathological diagnosis in atypical tuberculous spondylitis: a case series and clinical outcomesMing Lu, Wei Chen, Zixiong Lei, et al.
Medicine|June 23, 2020
Management of adult patients with type 1 diabetes mellitus in Africa: A post-hoc cohort analysis of 12 African countries participating in the International Diabetes Management Practices Study (Wave 7)Jean Claude Mbanya, Poobalan Naidoo, Babatope Ayodeji Kolawole, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 4, 2020
HIV and SARS-CoV-2 co-infection: The diagnostic challenges of dual pandemicsA Parker, J Shaw, S Karamchand, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|February 14, 2020
PCSK9 Inhibitors: From Nature's Lessons to Clinical UtilityFrederick J Raal, Robert Chilton, Naresh Ranjith, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
Bad company? The pericardium microbiome in people investigated for tuberculosis pericarditis in an HIV-prevalent settingGeorgina Nyawo, Charissa Naidoo, Benjamin G Wu, et al.
Microbes and Infection|November 11, 2024
Bad company? The pericardium microbiome in people investigated for tuberculous pericarditis in an HIV-prevalent settingGeorgina Nyawo, Charissa C Naidoo, Benjamin G Wu, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 4, 2020
Leadership and early strategic response to the SARS-CoV-2 pandemic at a COVID-19 designated hospital in South AfricaA Parker, S Karamchand, N Schrueder, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
JMIR Research Protocols|March 10, 2025
Novel Versus Conventional Sequencing of β-Blockers, Sodium/Glucose Cotransportor 2 Inhibitors, Angiotensin Receptor-Neprilysin Inhibitors, and Mineralocorticoid Receptor Antagonists in Stable Patients With Heart Failure With Reduced Ejection Fraction (NovCon Sequencing Study): Protocol for a Randomized Controlled TrialSumanth Karamchand, Tsungai Chipamaunga, Poobalan Naidoo, et al.
Annals of Translational Medicine|November 17, 2022
Image-guided percutaneous biopsy and pathological diagnosis in atypical tuberculous spondylitis: a case series and clinical outcomesMing Lu, Wei Chen, Zixiong Lei, et al.
Medicine|June 23, 2020
Management of adult patients with type 1 diabetes mellitus in Africa: A post-hoc cohort analysis of 12 African countries participating in the International Diabetes Management Practices Study (Wave 7)Jean Claude Mbanya, Poobalan Naidoo, Babatope Ayodeji Kolawole, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 4, 2020
HIV and SARS-CoV-2 co-infection: The diagnostic challenges of dual pandemicsA Parker, J Shaw, S Karamchand, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|February 14, 2020
PCSK9 Inhibitors: From Nature's Lessons to Clinical UtilityFrederick J Raal, Robert Chilton, Naresh Ranjith, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
Bad company? The pericardium microbiome in people investigated for tuberculosis pericarditis in an HIV-prevalent settingGeorgina Nyawo, Charissa Naidoo, Benjamin G Wu, et al.
Microbes and Infection|November 11, 2024
Bad company? The pericardium microbiome in people investigated for tuberculous pericarditis in an HIV-prevalent settingGeorgina Nyawo, Charissa C Naidoo, Benjamin G Wu, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 4, 2020
Leadership and early strategic response to the SARS-CoV-2 pandemic at a COVID-19 designated hospital in South AfricaA Parker, S Karamchand, N Schrueder, et al.
Pageof 5